U.S., Nov. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07225556) titled 'A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy' on Oct. 20.
Brief Summary: The purpose of this study is to look at how safe and well-tolerated LY4167586 is in participants with obesity or overweight who are otherwise healthy. Blood tests will be performed to check how much LY4167586 gets into the bloodstream and how long it takes the body to eliminate it following a single administration. Participation in the study will last approximately 7 months.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: LY4167586
Administered SC
DRUG:...